Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RASAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZBTB7C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDN10-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
VIPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NTNG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMY3AP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABI3BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KAT6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCAP29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL5A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGTR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NLRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105369748 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
QDPR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEU2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on